-+ 0.00%
-+ 0.00%
-+ 0.00%

Nahdi Medical's (TADAWUL:4164) Soft Earnings Are Actually Better Than They Appear

Simply Wall St·11/15/2026 05:23:48
语音播报

Soft earnings didn't appear to concern Nahdi Medical Company's (TADAWUL:4164) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.

earnings-and-revenue-history
SASE:4164 Earnings and Revenue History November 15th 2026

A Closer Look At Nahdi Medical's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. This ratio tells us how much of a company's profit is not backed by free cashflow.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Over the twelve months to September 2026, Nahdi Medical recorded an accrual ratio of -0.20. That implies it has very good cash conversion, and that its earnings in the last year actually significantly understate its free cash flow. Indeed, in the last twelve months it reported free cash flow of ر.س1.2b, well over the ر.س798.6m it reported in profit. Nahdi Medical shareholders are no doubt pleased that free cash flow improved over the last twelve months.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Nahdi Medical's Profit Performance

Happily for shareholders, Nahdi Medical produced plenty of free cash flow to back up its statutory profit numbers. Because of this, we think Nahdi Medical's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! Unfortunately, though, its earnings per share actually fell back over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example - Nahdi Medical has 1 warning sign we think you should be aware of.

Today we've zoomed in on a single data point to better understand the nature of Nahdi Medical's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.